# Liposomal Bupivacaine in Vaginal Hysterectomy

> **NCT03907033** · PHASE4 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 28 (actual)

## Conditions studied

- Vaginal Hysterectomy

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine Hydrochloride

## Key facts

- **NCT ID:** NCT03907033
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-03
- **Primary completion:** 2021-07-23
- **Final completion:** 2021-07-23
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Insufficient funding to continue with study activities
- **Last updated:** 2021-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03907033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03907033, "Liposomal Bupivacaine in Vaginal Hysterectomy". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03907033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*